IEX •
Healthcare •
Biotechnology •
Quote as of 05/15/2026 15:59
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeIEX
Market Capitalization176.5 mln
Float57.72 mln
Earnings Date05/22/2026
EPS
25.48
Exceptional
P / E
0.03
Anomalous
Piotroski F-Score
4
/ 9
Borderline
Relative Strength
10
/ 100
Significantly lagging
Debt / Equity
0.00
Debt-free
ROE
306
Extraordinary
Business Description
Enlivex is an Israeli biotech company founded in 2005 and based in Ness Ziona, focused on developing a cell-based treatment called Allocetra that works by retraining immune cells known as macrophages. The company is testing this therapy across several serious medical conditions, including knee joint disease, jaw joint disorders, and life-threatening organ failure caused by sepsis. Clinical trials are currently underway at various stages for each of these conditions.
